← Eichor
Condition: Thyroid Cancer Patients Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Thyroid Cancer Patients

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer
Phase 4 · 8 location(s) · Fudan University · NCT06195228Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Phase 1/Phase 2 · 27 location(s) · Institut de Recherches Internationales Servier · NCT05786924An International Study on Pediatric Patients With Rare Tumors.
Phase N/A · 1 location(s) · Azienda Ospedaliera di Padova · NCT07072143Safety & Feasibility of Ultrasound-assisted Non-invasive Measurement of Compressibility of the Thyroid Gland in Patients
NA · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT07102264A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
Phase N/A · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT05733013Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06779747Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department
NA · 4 location(s) · Institut du Cancer de Montpellier - Val d'Aurelle · NCT04104529Head-to-head Study of 68Ga-MGS5 Versus 68Ga-DOTATATE PET/CT in Patients With Medullary Thyroid Carcinoma
Phase 1 · 1 location(s) · First Affiliated Hospital of Fujian Medical University · NCT06520319Health-Related Quality of Life and Emotions in Patients with Thyroid Nodules
Phase N/A · 1 location(s) · Ming-an Yu · NCT06610604Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Phase 2 · 5 location(s) · Children's Hospital of Philadelphia · NCT05783323Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Phase N/A · 9 location(s) · Children's Hospital of Philadelphia · NCT05024929Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
Phase 2 · 5 location(s) · Children's Hospital of Philadelphia · NCT06458036Navigation Intervention for Adolescent and Young Adult Cancer Survivors
NA · 1 location(s) · Kaiser Permanente · NCT07406087Patient-centered Dosage of Levothyroxine
NA · 3 location(s) · University Hospital of North Norway · NCT06455371Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Phase 1/Phase 2 · 6 location(s) · ModeX Therapeutics, An OPKO Health Company · NCT06239194Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and
Phase 2 · 1 location(s) · Gustave Roussy, Cancer Campus, Grand Paris · NCT07016230I-124 PET/CT Imaging and Dosimetry for RAI-Naïve or Refractory Thyroid Cancer
Phase N/A · 1 location(s) · Miami Cancer Research Center, Inc. · NCT06443866A Phase I Trial of Af-001 in Patients With Differentiated Thyroid Cancer
Phase 1 · 1 location(s) · Alpha Fusion Inc. · NCT07287748An Observational Study on Postoperative Symptoms After Thyroidectomy (POS-T)
Phase N/A · 3 location(s) · Ilsan Cha hospital · NCT06158360Thyroid Carcinoma in Cancer Patients Undergoing Radiotherapy
Phase N/A · 2 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT07473518Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer
Phase 2 · 1 location(s) · Beijing Scitech-Mq Pharmaceuticals Limited · NCT06359847A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · 165 location(s) · Turning Point Therapeutics, Inc. · NCT03093116Ganoderma Spores Modulate the Gut-Brain Axis
NA · 1 location(s) · Ling Zhiqiang · NCT07524777Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules
Phase N/A · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT04742608Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer
NA · 1 location(s) · Zhejiang Provincial People's Hospital · NCT07068542A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer.
Phase 3 · 1 location(s) · Second Affiliated Hospital of Xi'an Jiaotong University · NCT06791005DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cance
Phase 2/Phase 3 · 16 location(s) · Cancer Research UK · NCT05768178A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carc
Phase 3 · 35 location(s) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06860971DESTINY-PANTUMOUR04
Phase N/A · 18 location(s) · AstraZeneca · NCT07124000Methimazole in Patients With Progressive Glioblastoma
Phase 2 · 1 location(s) · Case Comprehensive Cancer Center · NCT05607407
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.